Orchard Therapeutics' (NASDAQ: ORTX) Shares Skyrocket: How To Predict Biotech M&A
Orchard Therapeutics (NASDAQ: ORTX) experienced a remarkable 97% surge in its shares following a major announcement on October 5th, 2023. The renowned global gene therapy leader, Orchard, has been successfully acquired by Kyowa Kirin (OTC: KYKOF), solidifying its position as a fully owned subsidiary. The Agreement: The agreement outlines that Kyowa plans to buy all
United States Bristol Myers Squibb Orchard Therapeutics Kyowa Kirin Orchard Therapeutic Contingent Value
Source: microcapdaily.com